Any current/future capex/capital investment/strategic investment?

Current CAPEX for FY25 (9 months) excluding recent land acquisition is around Rs. 100 crores, mainly for Dombivli and Indore projects. Total planned CAPEX for three new hospitals (Dombivli, Pune 2 at Bibvewadi, Mira Road) is approximately Rs. 1,400 crores. Land acquisition in Mira Road for around Rs. 75 crores, fully funded through internal accruals and equity reserves. Mira Road hospital planned as a 300-bed full-service multi-specialty hospital with an estimated total CAPEX of Rs. 400 crores (including land). Dombivli hospital expected operational by Q1 FY27 with staggered investment. The co

Future growth expectations in sales/revenue/volumes?

Revenue for Q3 FY25 stood at Rs. 322 crores, a 17.7% YoY increase; 9-month revenue was Rs. 934.8 crores, up 19.5% YoY. Volume increased from 651,500 to 727,500 in 9 months. Occupancy improved to 66.7% from 63.2% YoY. ARPOB (Average Revenue Per Occupied Bed) increased to Rs. 59,100 from Rs. 53,600 YoY. Expansion via three new hospitals (Dombivli 500 beds by Q1 FY27, Pune 500 beds by 2028, Mira Road 300 beds by 2029) aims to increase bed capacity to ~2,500. Industry norm suggests new hospitals will be EBITDA negative in year 1, breakeven in year 2, and positive in year 3. Demand in catchment are

Future growth expectations in earnings/operating earnings/profits/EPS?

Jupiter Life Line Hospitals anticipates initial EBITDA losses for new hospitals in the first year, with breakeven expected by the second year and profitability by the third year. Margin expansion levers include inflation-linked price hikes (Thane), occupancy growth (Pune), and case mix optimization (Indore) expected to continue for 1-1.5 years. Occupancy rates are poised to improve, with current occupancy around 65-66%, and planned bed additions to manage demand. ARPOB is increasing (Rs 61,750 in Q3 FY25 vs. Rs 59,100 in 9 months FY25), supporting revenue growth. The company projects growing i

Current/ Expected Orderbook/ Pending Orders?

Jupiter Life Line Hospitals has a pipeline of three new hospitals in addition to the existing three operational ones. New hospitals planned: - Dombivli: 500 beds, expected operational by Q1 FY27. - Pune 2 (Bibvewadi): 500 beds, expected operational in calendar year 2028. - Mira Road: 300 beds, expected operational in calendar year 2029. Total bed capacity after new hospitals will be approximately 2,500 beds. Estimated CAPEX for these three hospitals is around Rs. 1,400 crores. Recent land acquisition in Mira Road was for Rs. 75 crores, part of the Rs. 400 crore estimated CAPEX for that h

IN US

Sale is live|00:00:00left today

Jupiter Life Line Hospitals LtdQ4 FY26Healthcare Services

Jupiter Life Line Hospitals Ltd Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,381P/E: 44.0Market Cap: ₹8.7K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

→Revenue for Q3 FY25 stood at Rs. 322 crores, a 17.7% YoY increase; 9-month revenue was Rs. 934.8 crores, up 19.5% YoY.
→Volume increased from 651,500 to 727,500 in 9 months.
→Occupancy improved to 66.7% from 63.2% YoY.
→ARPOB (Average Revenue Per Occupied Bed) increased to Rs. 59,100 from Rs. 53,600 YoY.
→Expansion via three new hospitals (Dombivli 500 beds by Q1 FY27, Pune 500 beds by 2028, Mira Road 300 beds by 2029) aims to increase bed capacity to ~2,500.
→Industry norm suggests new hospitals will be EBITDA negative in year 1, breakeven in year 2, and positive in year 3.
→Demand in catchment areas, such as Mira Bhayandar with 2-3 million underserved residents, can drive volume growth.
→Margins expected to improve with occupancy growth, price hikes, and case-mix optimization, particularly in Pune and Indore.

Margin guidance

Category 3

→Jupiter Life Line Hospitals anticipates initial EBITDA losses for new hospitals in the first year, with breakeven expected by the second year and profitability by the third year.
→Margin expansion levers include inflation-linked price hikes (Thane), occupancy growth (Pune), and case mix optimization (Indore) expected to continue for 1-1.5 years.
→Occupancy rates are poised to improve, with current occupancy around 65-66%, and planned bed additions to manage demand.
→ARPOB is increasing (Rs 61,750 in Q3 FY25 vs. Rs 59,100 in 9 months FY25), supporting revenue growth.
→The company projects growing internal accruals without immediate need for additional debt, supporting capital expenditure for new hospitals.
→With three new hospitals planned by FY27-FY29, revenue and profits are expected to scale up steadily as these facilities stabilize and grow.

3 more insights locked — sign up free to unlock

Fundraise plans

- For the three new hospitals planned (Dombivli, Pune 2 in Bibvewadi, Mira Road), no additional debt is currently planned. - The company intends to fund these projects through internal accruals and existing cash reserves. - The current cash on books is Rs. 250+ crores and nine-month EBITDA is Rs. 218 crores. - Since the hospital expansions are greenfield projects, CAPEX expenditure is staggered, allowing cash deployment as it is generated. - If future opportunities arise beyond the current three hospitals, the board will evaluate the need to raise debt, equity, or a mix of both at that time. - Financing decisions will be made based on the nature and timing of those opportunities. In summary, no immediate plans for fresh fundraising through debt or equity; current projects will be funded via internal resources, with future funding evaluated as needed.

Order book

→Jupiter Life Line Hospitals has a pipeline of three new hospitals in addition to the existing three operational ones.
→New hospitals planned:
→ - Dombivli: 500 beds, expected operational by Q1 FY27.
→ - Pune 2 (Bibvewadi): 500 beds, expected operational in calendar year 2028.
→ - Mira Road: 300 beds, expected operational in calendar year 2029.
→Total bed capacity after new hospitals will be approximately 2,500 beds.
→Estimated CAPEX for these three hospitals is around Rs. 1,400 crores.
→Recent land acquisition in Mira Road was for Rs. 75 crores, part of the Rs. 400 crore estimated CAPEX for that hospital.
→Funding for the CAPEX will come from current cash reserves, internal accruals, and no immediate additional debt is planned.
→No formal EBITDA loss guidance, but first-year EBITDA expected negative and breakeven by the second year for new hospitals.

Capex plans

Yes

→Current CAPEX for FY25 (9 months) excluding recent land acquisition is around Rs. 100 crores, mainly for Dombivli and Indore projects.
→Total planned CAPEX for three new hospitals (Dombivli, Pune 2 at Bibvewadi, Mira Road) is approximately Rs. 1,400 crores.
→Land acquisition in Mira Road for around Rs. 75 crores, fully funded through internal accruals and equity reserves.
→Mira Road hospital planned as a 300-bed full-service multi-specialty hospital with an estimated total CAPEX of Rs. 400 crores (including land).
→Dombivli hospital expected operational by Q1 FY27 with staggered investment.
→The company intends to fund these projects largely through existing cash reserves (Rs. 250+ crores), internal accruals, and cash flow without additional debt for now.
→Possibility of future funding through debt or equity will be evaluated if new projects arise beyond these three hospitals.

How does Jupiter Life Line Hospitals Ltd rank vs peers in Healthcare Services?

Pro feature

1Jupiter Life Line Hospitals Ltd

Rev 2Mar 3

See full Healthcare Services sector rankings

Want more stocks like Jupiter Life Line Hospitals Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio